, /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage immunology company, announced today that it will participate in the Jefferies Healthcare Conference Private Biotech Day, taking place , in . Company management will be conducting one-on-one meetings with investors at the conference.
Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in For additional information, please visit and follow us on and . For collaborative interests, write to .
Juniper Point SOURCE Myeloid Therapeutics, Inc..